Press Releases

BALTIMORE, Sept. 23, 2019 /PRNewswire/ -- KaloCyte, a preclinical-stage healthcare biotechnology company developing a synthetic, bio-inspired red blood cell substitute for use in settings when sto

WILMINGTON, Del., Sept. 23, 2019 /PRNewswire/ -- Castle Connolly Private Health Partners, LLC ("CCPHP"), a leading membership-based (or "concierge") practice conversion and support company, is pleased to announce a collaboration with Dr. Marc D. Grobman to establish a concierge medicine program at his practice.

binx FDA-cleared platform already impacting human health—poised to transform care for millions BOSTON, Sept. 23, 2019 /PRNewswire/ -- binx health, the pioneer in anywhere, anytime testing for women's health, today announced the first real-world use of the binx io platform, delivering same-visit diagnosis and treatment for chlamydia (CT)

TAMPA, Fla., Sept. 23, 2019 /PRNewswire/ -- Studies show "social determinants of health" – the conditions in which people live, learn, work and play – affect a wide range of health risks and outcomes. New data released today by WellCare Health Plans, Inc. (NYSE: WCG) ("WellCare") adds to the growing body of research by examining the social service needs in h

PALO ALTO, Calif., Sept. 23, 2019 /PRNewswire/ -- Varian (NYSE: VAR) today announced the United States Trade Representative (USTR) has granted exclusion of components sourced from China for linear accelerators manufactured in the U.S from Section 301 tariffs. The exemption became effective on September 20, 2019."We are

World-renowned faculty will present current evidence and potential clinical applications of CTCs for advanced breast and prostate cancer BOLOGNA, Italy and HUNTINGDON VALLEY, Pa., Sept. 23, 2019 /PRNewswire/ -- Menarini Silicon Biosystems, the pioneer of liquid biopsy and rare cell technologies, will host a symposium

ALBANY, N.Y., Sept. 23, 2019 /PRNewswire/ -- Healthy Alliance Independent Practice Association (IPA), Innovative Health Alliance of New York, LLC (IHANY), and Fidelis Care are partnering to provide critical funding and careful coordination of services to Medicaid members insured by

SAN DIEGO, and VANCOUVER, British Columbia, Sept. 23, 2019 /PRNewswire/ -- Phoenix Molecular Designs (PhoenixMD), a clinical stage biotechnology company developing precise cancer

HUNT VALLEY, Md., Sept. 23, 2019 /PRNewswire/ -- Pharmaceutics International, Inc. (Pii), a Contract Development and Manufacturing Organization (CDMO) headquartered in Hunt Valley, Maryland, is pleased to announce the  commercial supply of Fulvestrant Injection 250mg/5ml drug product, which was recently approved by the FDA.  Pi

NEW YORK, Sept. 23, 2019 /PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) ("Actinium") today announced that a poster highlighting Iomab-B, its pivotal Phase 3 targeted conditioning candidate, was awarded Honorable Distinction at the 2019 SOHO (Society of Hematologic Oncology) Annual Meeting. SOHO is the only international society specific